Brian D. Acker

The effect of hydralazine on the tumor cytotoxicity of the hypoxic cell cytotoxin RSU-1069: Evidence for therapeutic gain

David J. Chaplin, Brian D. Acker · International Journal of Radiation Oncology*Biology*Physics · 1987 · 142 citations

Tumor Cytotoxicity, Biochemistry, Chemoprevention Strategy +7

Small Cell Carcinoma of the Cervix Treated with Concurrent Radiotherapy, Cisplatin, and Etoposide

Paul Hoskins, Frances Wong, K. Swenerton et al. · Gynecologic Oncology · 1995 · 64 citations

Cervical Cancer Management, Cervical Cancer, Radiation Therapy +9

Potentiation of the tumor cytotoxicity of melphalan by vasodilating drugs

David J. Chaplin, Brian D. Acker, Peggy L. Olive · International Journal of Radiation Oncology*Biology*Physics · 1989 · 47 citations

Tumor Cytotoxicity, Chemoprevention Strategy, Medicine +5

The management of carcinoma of the anal canal by external beam radiotherapy, experience in Vancouver 1971–1988

Gemma Newman, David C. Calverley, Brian D. Acker et al. · Radiotherapy and Oncology · 1992 · 41 citations

Radiation Medicine, Surgical Oncology, Radiation Therapy +8

Histological evidence for nonperfused vasculature in a murine tumor following hydralazine administration

Martin J. Trotter, Brian D. Acker, David J. Chaplin · International Journal of Radiation Oncology*Biology*Physics · 1989 · 38 citations

Murine Tumor, Hydralazine Administration, Medicine +3